Original Source(s)
Related Content
Second Primary Cancer Risk Shifts Over Time
US registry study finds overall declines but rising risk in lung, melanoma, and older survivor groups
May 5, 2026
-
5 min
IOPTH Widely Used, Variation Persists
Most surgeons reported using intraoperative parathyroid hormone monitoring, but approaches to imaging and intraoperative criteria varied, particularly in secondary and tertiary disease
April 13, 2026
-
3 min
FDA Approves New First-Line TNBC Regimen
Phase 3 results showed longer progression-free survival with pembrolizumab plus sacituzumab govitecan-hziy than with pembrolizumab plus chemotherapy in previously untreated PD-L1-positive advanced triple-negative breast cancer.
June 26, 2026
-
3 min